Reply
- 31 August 2002
- journal article
- other
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 110 (2) , 325-328
- https://doi.org/10.1067/mai.2002.126376
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Comparative efficacy of levalbuterol and racemic albuterol in the treatment of asthmaJournal of Allergy and Clinical Immunology, 2002
- Levalbuterol has not been established to have therapeutic advantage over racemic albuterolJournal of Allergy and Clinical Immunology, 2002
- Impact of decreasing doses of racemic albuterol and levalbuterol on efficacy: A pooled analysisJournal of Allergy and Clinical Immunology, 2002
- Low-dose levalbuterol in children with asthma: Safety and efficacy in comparison with placebo and racemic albuterolJournal of Allergy and Clinical Immunology, 2001
- The therapeutic ratio of R-albuterol is comparable with that of RS-albuterol in asthmatic patientsJournal of Allergy and Clinical Immunology, 2001
- Asthma from the perspective of the patientJournal of Allergy and Clinical Immunology, 1999
- Bronchoprotective and bronchodilator effects of single doses of ( S )-salbutamol, ( R )-salbutamol and racemic salbutamol in patients with bronchial asthmaEuropean Journal of Clinical Pharmacology, 1999
- Tolerance to the bronchoprotective effect of β2 -agonists: Comparison of the enantiomers of salbutamol with racemic salbutamol and placeboJournal of Allergy and Clinical Immunology, 1999
- The safety and efficacy of nebulized levalbuterol compared with racemic albuterol and placebo in the treatment of asthma in pediatric patientsJournal of Allergy and Clinical Immunology, 1999
- Improved bronchodilation with levalbuterol compared with racemic albuterol in patients with asthmaJournal of Allergy and Clinical Immunology, 1998